Fidelity Select Portfolios · net assets $5.35B · 191 holdings as of February 28, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 96.9% · STIV: 2.6% · EP: 0.5%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $85.4M | $55.1M | $23.8M |
| Reinvestment | $105M | $0 | $0 |
| Redemptions | $74.4M | $92.7M | $63.2M |
| Net realized gain (non-derivative) | $36.5M | $42.5M | $104M |
| Net unrealized appreciation (non-derivative) | $-78.9M | $31.4M | $21.2M |
The three months of the reporting period, as filed; month 3 ends February 28, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Abbvie Inc EC | $708M | 13.22% |
| Krystal Biotech Inc EC | $498M | 9.30% |
| Gilead Sciences Inc EC | $469M | 8.77% |
| Amgen Inc EC | $446M | 8.34% |
| Alnylam Pharmaceuticals Inc EC | $165M | 3.09% |
| Fidelity Revere Street Trust STIV | $136M | 2.55% |
| Praxis Precision Medicines Inc. EC | $132M | 2.46% |
| Ascendis Pharma A/s EC | $130M | 2.44% |
| Insmed Inc EC | $121M | 2.26% |
| Ucb Sa EC | $116M | 2.17% |
| Argenx Se EC | $115M | 2.14% |
| Regeneron Pharmaceuticals Inc EC | $79.2M | 1.48% |
| Moderna Inc EC | $76.7M | 1.43% |
| Scholar Rock Holding Corp EC | $73.1M | 1.37% |
| Natera Inc EC | $69M | 1.29% |
| Cogent Biosciences Inc EC | $65.7M | 1.23% |
| Centessa Pharmaceuticals PLC EC | $58.8M | 1.10% |
| Biogen Inc EC | $57.4M | 1.07% |
| Roivant Sciences Ltd EC | $57.1M | 1.07% |
| Vertex Pharmaceuticals Inc EC | $56.1M | 1.05% |
| Bridgebio Pharma Inc EC | $47M | 0.88% |
| Protagonist Therapeutics Inc EC | $46.7M | 0.87% |
| Immunome Inc EC | $46.6M | 0.87% |
| Terns Pharmaceuticals Inc EC | $45.5M | 0.85% |
| Revolution Medicines Inc EC | $44.8M | 0.84% |
| Kymera Therapeutics Inc EC | $42.2M | 0.79% |
| Ionis Pharmaceuticals Inc EC | $38.7M | 0.72% |
| Arrivent Biopharma Inc EC | $38.6M | 0.72% |
| Crinetics Pharmaceuticals Inc EC | $38.1M | 0.71% |
| Abivax Sa EC | $36.6M | 0.68% |
| Structure Therapeutics Inc EC | $35.5M | 0.66% |
| Disc Medicine Inc EC | $35.5M | 0.66% |
| Galderma Group Ag EC | $34.8M | 0.65% |
| Zealand Pharma A/s EC | $33.9M | 0.63% |
| Cytokinetics Inc EC | $31.3M | 0.59% |
| Candel Therapeutics Inc EC | $31M | 0.58% |
| Viridian Therapeutics Inc EC | $29.4M | 0.55% |
| Vaxcyte Inc EC | $29M | 0.54% |
| Stoke Therapeutics Inc EC | $28.9M | 0.54% |
| Nuvalent Inc EC | $27.9M | 0.52% |
| Apogee Therapeutics Inc EC | $27.5M | 0.51% |
| Trevi Therapeutics Inc EC | $27.3M | 0.51% |
| Annexon Inc EC | $26.5M | 0.50% |
| Arrowhead Pharmaceuticals Inc EC | $25.9M | 0.48% |
| Dianthus Therapeutics Inc EC | $23.9M | 0.45% |
| Vor Biopharma Inc EC | $23.7M | 0.44% |
| Edgewise Therapeutics Inc EC | $23.6M | 0.44% |
| United Therapeutics Corp Del EC | $22.5M | 0.42% |
| Intellia Therapeutics Inc EC | $22.2M | 0.41% |
| Travere Therapeutics Inc EC | $21.5M | 0.40% |
| Dyne Therapeutics Inc EC | $21.4M | 0.40% |
| Bio Ab Holdings LLC EC | $20.7M | 0.39% |
| Corcept Therapeutics Inc EC | $20.6M | 0.38% |
| Ideaya Biosciences Inc EC | $20.5M | 0.38% |
| Madrigal Pharmaceuticals Inc EC | $20.5M | 0.38% |
| Newamsterdam Pharma Company Nv EC | $19.9M | 0.37% |
| Amylyx Pharmaceuticals Inc EC | $18.5M | 0.35% |
| Biohaven Ltd EC | $18.5M | 0.35% |
| Summit Therapeutics Inc EC | $18.1M | 0.34% |
| Spyre Therapeutics Inc EC | $17.3M | 0.32% |
Showing top 60 of 191 holdings.
Loading...
